MedDRA 10.0 Review. Terminology Files: What you need to know. MedDRA Version 10.0 Terminology Frequency Distribution

Size: px
Start display at page:

Download "MedDRA 10.0 Review. Terminology Files: What you need to know. MedDRA Version 10.0 Terminology Frequency Distribution"

Transcription

1 MedDRA 10.0 Review MedDRA Version Changes General Remarks Terminology Files: What you need to know MedDRA Version 10.0 Specific Changes Version 10.0 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 10.0 Terminology Frequency Distribution MedDRA Version What's coming ahead?

2 MedDRA Changes - General Remarks There are two possible types of changes to MedDRA terminology: simple changes and complex changes. Simple changes are changes to the existing terminology that involve terms at the PT and LLT levels. There are two types of Simple changes: (1) changes introduced by subscribers request and (2) Maintenance changes (also referred to as Associate changes). Maintenance changes are generated as a by-product of other changes requested by subscribers, or changes introduced by the MedDRA Management Board to preserve consistency within the dictionary. Complex changes involve modifications to HLT, HLGT, and SOC terminology. Currently, the initial MedDRA terminology version release in one specific year (5.0, 6.0, 7.0, 8.0, 9.0) includes both simple and complex changes, and the subsequent release in the same year (5.1, 6.1, 7.1, 8.1, 9.1) represents a simple change of terminology. These changes are based on MedDRA subscribers' terminology change requests and on MedDRA terminology maintenance needs identified by MedDRA's maintenance organization reviewers. Please note that as a consequence of implementing some of these changes (e.g. demoting a multiaxial PT, adding a new HLT, etc.) it may be necessary to break the multiaxial links, to re-link the replacement terms, and/or to enable additional terms to be included within a particular SOC. All these changes may require modifications to your existing MedDRA coding, guideline development, and data retrieval practices. Back to MedRA 10.0 Review

3 Files Containing MedDRA Terminology,Documentation, and Terminology Changes Information Directory Folder File Name Description How to use it _ intguide.pdf MedDRA Introductory Guide is a language specific document that describes characteristics of MedDRA including rules, conventions, and terminology hierarchy To view requires Adobe Acrobat reader. smq_intguide.pdf whatsnew.pdf SMQ Introductory Guide is a document that describes SMQs basic concepts The "What's New" document provides a summary of all corresponding MedDRA version changes, modifications to terminology conventions, and information on other MedDRA-related activities To view requires Adobe Acrobat reader. To view requires Adobe Acrobat reader. _ asciidoc.pdf MedDRA ASCII Files Documentation contains MedDRA files' description and To view requires Adobe fields definitions. In addition, it Acrobat reader. contains all the information required to create MedDRA relational _ conseq.pdf MedDRA Consecutive File Documentation contains consecutive files' description and fields definitions. To view requires Adobe Acrobat reader. _ changereq_info.pdf sub_pot.pdf phonecard.pdf Change Request Information document provides all information regarding terminology change requests Subscriber Portfolio document contains details about your MedDRA subscription MedDRA MSSO Phone System provides information on how to access the MSSO by phone To view requires Adobe Acrobat reader. To view requires Adobe Acrobat reader. To view requires Adobe Acrobat reader.

4 _!!readme.txt Readme document contains a list of all documents included in each new MedDRA version release. To view requires any reader that supports *.txt files Directory Folder File Name Description How to use it llt.asc Lower Level Term file. Contains ALL LLT in the hierarchy including noncurrent terms Refer to PDF document ascii.pdf for a complete description of this file's content and how to format it to create a table in a relational database pt.asc Prefer Term file. Contains all PT in the hierarchy. hlt.asc High Level Term file. Contains all HLT in the hierarchy. hlgt.asc High Level Group Term file. Contains all HLGT in the hierarchy. soc.asc System Organ Class file. Contains all 26 SOCs in the hierarchy. mdhier.asc MedDRA Hierarchy file. Contains the MedDRA hierarchy excluding LLTs.

5 hlt_pt.asc PT & HLT codes file. Contains all PT-HLT associations. (most recent version hlgt_hlt.asc HLT & HLGT codes file.contains all HLT-HLGT associations. soc_hlgt.asc HLGT & SOC codes file. Contains all HLGT-SOC associations. spec.asc Special Search Categories (SSC) file. Contains a list of all Special Search Categories. spec_pt.asc Special Search Categories & PT file. Contains a list of all Special Search Categories (SSC) and the PTs included in each. SMQ_List.asc Standardised MedDRA Query (SMQ) list file. Contains a complete list of all production (means available for use) SMQs. SMQ_Content.asc Standardised MedDRA Query (SMQ) content file. Contains all production SMQs and their respective subordinate terms. intl_ord.asc International System Organ Class order file. Contains the serial code for international System Organ Class sort order (based on relative importance of each SOC)

6 Directory Folder File Name Description How to use it SeqAscii llt.seq Lower Level Term sequential file. Contains all LLT changes since previous version. conseq.pdf document to use in a relational SeqAscii pt.seq Prefer Term file. Contains all PT changes since previous version. conseq.pdf document to use in a relational SeqAscii hlt.seq High Level Term file. Contains all HLT changes since previous version. conseq.pdf document to use in a relational SeqAscii hlgt.seq High Level Group Term file. Contains all HLGT changes since previous version. conseq.pdf document to use in a relational SeqAscii soc.seq System Organ Class file. Contains all SOCs changes since previous version. conseq.pdf document to use in a relational SeqAscii mdhier.seq MedDRA Hierarchy file. Contains the MedDRA hierarchy changes since previous version. conseq.pdf document to use in a relational SeqAscii hlt_pt.seq PT & HLT codes file. Contains all PT-HLT changes since previous version. conseq.pdf document to use in a relational SeqAscii hlgt_hlt.seq HLT & HLGT codes file. Contains all HLT-HLGT changes since previous version. conseq.pdf document to use in a relational

7 (most recent version SeqAscii soc_hlgt.seq HLGT & SOC codes file.contains all HLGT-SOC associations. conseq.pdf document to use in a relational SeqAscii SeqAscii SeqAscii spec.seq spec_pt.seq intl_ord.seq Special Search Categories (SSC) file. Contains a list of all Special Search Categories changes since previous version. conseq.pdf document to use in a relational Special Search Categories & PT file. Contains a list of all Special conseq.pdf document to Search Categories (SSC) and use in a relational the PTs changes since previous version. International System Organ Class order file. Contains all changes to the serial code for international System Organ Class sort order (based on relative importance of each SOC) conseq.pdf document to use in a relational Directory Folder File Name Description How to use it MedDRA MSSO Downloads Page: so.com/translations/ downloads.htm _ MedDRAVersion Reports.xls MedDRA Verison Report file. Contains all MedDRA terminology changes since previous version release in a spreadsheet format. Microsoft Excel format. Very useful file for MedDRA version upgrade reviews. MedDRA MSSO Downloads Page: so.com/translations/ downloads.htm _ Detailed_WhatsNew Report.pdf Detailed What's New Report file. Contains all version changes in full detail. To view requires Adobe Acrobat reader. Very useful file for MedDRA version upgrade reviews. Back to MedDRA 10.0 Review

8 MedDRA 10.0 Changes: Overview MedDRA Terminology Version 10.0 released in March 1, 2007 contains both simple and complex changes. Following is a summary of the changes and several examples. To view a complete list of all terminology changes in version 10.0 go to: Version Report - (subscriber login required). Changes In a Nutshell Retirement of SSCs 17 Complex Changes Double Spaced Terms and Other Existing Errors New SMQs Back to MedDRA 10.0 Review Changes Highlights Featured HLGT Changes Featured HLT Changes Featured PT Changes New PTs Promoted LLTs

9 Featured LLT Changes New LLTs Demoted PTs Currency changes Featured SMQ Changes New SMQs MedDRA Version What's coming ahead? Back to MedDRA 10.0 Review

10 MedDRA Version 10.0 Specific Changes Changes In a Nutshell Retirement of SSCs Special Search Categories (SSCs) have been replaced by Standardized MedDRA Queries (SMQs).?SSCs have been a part of the terminology since Version 2.1 (March 1999). From Version 10.0 and on the MSSO will discontinue the maintenance and distribution of SSCs. However, SSCs will be available to MedDRA users as archive files at the MSSO download page. 17 Complex Changes Back These 17 complex changes involve HLGTs and HLTs only. Two HLGTs and five HLTs were renamed. Five HLTs were merged under other HLTs. In addition, five new HLTs were added to the hierarchy. Renamed HLGTs Old Name New Name Infections - pathogen class unspecified Infections - pathogen unspecified Neurological, special senses and psychiatric Neurological and special sense investigations investigations Renamed HLTs Old Name New Name Cardiac pacemaker therapeutic procedures Cardiac device therapeutic procedures Scalar conditions Scaly conditions Sepsis, bacteraemia and viraemia Sepsis, bacteraemia, viraemia and fungaemia NEC Injuries due to in utero exposure Pregnancy related accidental exposures and injuries Narcolepsy associated symptoms Narcolepsy and associated conditions Merged HLTs

11 Merged HLT Diabetic eye disorders NEC Variola viral infections Vaccinia viral infections Australia viral infections Congenital cardiac valve disorders Merged Under Ocular disorders NEC Orthopox viral infections Orthopox viral infections Flaviviral infections Congenital cardiovascular disorders NEC New HLTs Merged HLT Diabetic eye disorders NEC Variola viral infections Vaccinia viral infections Australia viral infections Congenital cardiac valve disorders Merged Under Ocular disorders NEC Orthopox viral infections Orthopox viral infections Flaviviral infections Congenital cardiovascular disorders NEC The following tables present all PTs contained within each new HLT. HLT Biochemical markers of bone metabolism PT C-telopeptide PT Deoxypyridinoline urine increased PT Deoxypyridinoline/creatinine ratio PT N-telopeptide PT N-telopeptide urine PT N-telopeptide urine abnormal PT N-telopeptide urine decreased PT N-telopeptide urine increased PT N-telopeptide urine normal PT Osteocalcin PT Osteocalcin decreased PT Osteocalcin increased PT Osteoprotegerin PT Osteoprotegerin decreased PT Osteoprotegerin increased PT Osteoprotegerin ligand PT Osteoprotegerin ligand decreased PT Pyridinoline urine PT Pyridinoline urine decreased PT Pyridinoline urine increased

12 HLT Psychiatric Investigations PT Mini mental status examination PT Mini mental status examination abnormal PT Mini mental status examination normal PT Neuropsychological test PT Neuropsychological test abnormal PT Psychiatric evaluation PT Psychiatric evaluation abnormal PT Psychiatric evaluation normal PT Psychiatric investigation HLT Contraceptive Methods Male PT Condom PT Male contraception PT Male sterilisation HLT Orthopox viral infections PT Cow pox PT Smallpox PT Eczema vaccinatum PT Post vaccination autoinoculation PT Vaccinia PT PT PT PT PT PT PT PT PT Paraneoplastic syndromes NEC Eaton-Lambert syndrome Hypercalcaemia of malignancy Polyneuropathy in malignant disease Paraneoplastic cerebellar degeneration Paraneoplastic pemphigus Paraneoplastic syndrome Acrokeratosis paraneoplastica Paraneoplastic retinopathy Paraneoplastic dermatomyositis Back

13 Double Spaced Terms and Other Existing Errors Several terms in MedDRA contained spelling errors and/or double spacing sometimes causing data retrieval problems. Following is a complete list of all the corrected terms. LLT_Name_v91 Aminorrhea Ano-rectal stenosis Ano-rectal ulcer Blastomyces pnemonia recurrent Cerebellar or brain stem contu w /o ment of open intcran wound, with prol oss cons and rtrn to pecl Cerebral revasculariztion synangiosis Chronic obstructive asthma (with obstructive pulmonary disease), wlo ment of status asthmaticus Cns complications of anesthesia or other sedation in labor and delivery, unspec as to eoc Cns comps of anesthesia or other sedat labor and delivered, with men of postpart comp Dyspepsia aggravated Human immunodeficiency virus, type 2 infection in conditions classified elsewhere and of unspec sit Hypothalamo-pituitary disorders Inappropriate device irritation of tissue Kaschin-Beck disease involving multiple sites Kaschin-Beck disease involving other specified sites Kaschin-Beck disease involving pelvic region and thigh Mouth ulceration aggravated Oedema abdomen NOS Oth closed skull frac with intcran inj of oth and unspec nature, with prol Icc, w/o rtrn to pecl Oth open skull frac with intcran inj of oth and unspec nature, with prolonged loss of Other current conditions classifiable elsewhere of mother, antepartum Pancreatic secretion decreased Pancreatic secretion increased PDA Repair patent ductus arteriosus Poisoning by mixed viral-ricket and bact vaccines, except combinations with pertussis component LLT_Name_v10 Amniorrhea Anorectal stenosis Anorectal ulcer Blastomyces pneumonia recurrent Cerebellar or brain stem contu w /o ment of open intcran wound, with prol_ loss cons and rtrn to pecl Cerebral revascularization synangiosis Chronic obstructive asthma (with obstructive pulmonary disease), w/o-ment of status asthmaticus Cns_complications of anesthesia or other sedation in labor and delivery, unspec as to eoc Cns_comps of anesthesia or other sedat labor and delivery, delivery, delivered, with men of postpart comp Dyspepsia-aggravated Human immunodeficiency virus, type 2_infection in conditions classified elsewhere and of unspec sit Hypothalamo-pituitary disorder Inappropriate device stimulation of tissue Kaschin-Beck disease_involving multiple sites Kaschin-Beck disease_involving other specified sites Kaschin-Beck disease_involving pelvic region and thigh Mouth ulceration-aggravated Oedema abdomen Oth closed skull frac with intcran inj of oth and unspec nature, with prol_loc, w /o rtrn to pecl Oth open skull frac with intcran inj of oth and unspec nature, w ith prolonged_loss of Other current conditions classifiable elsewhere of mother,_antepartum Pancreatic-secretion decreased Pancreatic-secretion increased PDA_Repair patent ductus arteriosus Poisoning by mixed viral-ricket and bact vaccines, except combinations with_pertussis component

14 Port-a-Cath insertion Progression of non small cell lung cancer Proteinuria aggravated Quadriplegia and quadriparesis of C1-C4, incomplete Sterilization NOS Subdural hem following inj, with open intcran wound, with moderate loc Portacath insertion Progression of non-small cell lung cancer Proteinuria-aggravated Quadriplegia and quadriparesis of_c1-c4, incomplete Sterilization Subdural hem following inj, with open intcran_wound, with moderate loc Back New SMQs 1. Adverse pregnancy outcome/reproductive toxicity (incl neonatal disorders) (SMQ) 2. Convulsions (SMQ) 3. Cardiac failure (SMQ) 4. Dementia (SMQ) 5. Embolic and thrombotic events (SMQ) 6. Extrapyramidal syndrome (SMQ) 7. Malignancies (SMQ) 8. Pre-malignant disorders (SMQ) 9. Pseudomembranous colitis (SMQ) For more details about these new SMQs, go to Changes Highlights, Featured SMQ Changes. Back to Changes in a Nutshell Or Back to MedDRA 10.0 Review Back

15 MedDRA Version 10.0 Specific Changes Changes Highlights Featured HLGT Changes See previous section: 17 Complex Changes Back Featured HLT Changes See previous section: 17 Complex Changes Back Featured PT Changes New PTs new PTs. Following are some examples. Promoted LLTs-40 LLTs promoted to

16 PT Name PT Inner ear inflammation PT Ocular surface disease PT Localised intraabdominal fluid collection PT Regurgitation PT Stomach mass PT Catheter thrombosis PT Surgical failure PT Disuse syndrome PT Treatment failure PT Vaccine positive rechallenge PT Post procedural infection PT Superinfection fungal PT Superinfection viral PT Superinfection bacterial PT Weaning failure PT Procedural nausea PT Deep vein thrombosis postoperative PT Procedural vomiting PT Procedural headache PT Procedural dizziness PT Device misuse PT Tumour related complication PT Hemisensory neglect PT Visual midline shift syndrome PT Progressive relapsing multiple sclerosis PT Taciturnity PT Violent ideation PT Polymedication Promoted LLTs-40 LLTs promoted to PT. Following are some examples. PT Name PT Altered state of consciousness PT Angioedema PT Atrioventricular block complete PT Carotid artery bypass PT Elective procedure PT Elective surgery PT Multiple injuries PT Nasal inflammation

17 Back Featured LLT Changes New LLTs-527 new LLTs. Following are a few examples. LLT Name PT Name New LLT Medication after taste Pharmaceutical product complaint New LLT Drug side effect Adverse drug reaction New LLT Pharmacodynamic interaction Drug interaction New LLT Pharmacokinetic interaction Drug interaction New LLT Menoxenia Menstrual disorder New LLT Emmeniopathy Menstrual disorder New LLT Uncontrolled hypertension Hypertension Demoted PTs - 68 PT were demoted to LLT level in version Following are some examples. LLT Name (former PTs in version 9.1) ABO isoimmunisation Herpetic gingivostomatitis Adherent leukoma Herpetic stomatitis Angioneurotic oedema Impingement syndrome Anticonvulsant toxicity Intestinal spasm Arteriopathic disease Intra-nasal antrostomy Atrioventricular block third degree Intranasal numbness Bronchitis acute Intubation complication Bronchitis acute viral Isoimmunisation Buttock pain Latissimus dorsi flap Carotid artery atheroma Low tension glaucoma Catheter site bruise Pneumatic retinopexy Conductive keratoplasty Polytraumatism Corneal epithelium disorder Post procedural dizziness Cryoretinopexy Post procedural headache Dacryocanaliculitis infective Post procedural nausea Dacryocystitis infective Post procedural vomiting Death of child Postoperative infection Death of friend Pulmonary coccidioides Death of parent Rebound hypertension Death of sibling Regurgitation of food Death of spouse Renal papillitis necrotising Descemet's membrane disorder Retinal naevus Detached retina repair Ross river virus infection Difficult to wean from ventilator Sacral pain

18 Dry socket Epithelioma Extrinsic iliac vein compression Familiar hemiplegic migraine Genital pain female Genital pain male Genital pruritus female Genital pruritus male Genitalia external painful Hepatic trauma Single vessel bypass graft Streptococcal serology Streptococcal serology negative Streptococcal serology positive Superinfection lung Superinfection oral Therapy non-responder Uterine cervix hypertrophy Vascular ultrasound Vessel puncture site bruise Back Currency changes - the following 22 LLTs were made Non-Current (inactive) in version 10.0 LLT Name AML progression Asthenia legs Blood gases abnorm Collapsed semi conscious & shocked Congenital musculoskeletal abnorm Familiar hemiplegic migraine Fear, focus Gases blood abnorm Haemangioma-thrombocytopaenia syndrome Hesitancy/poor urinary stream Liver function tests multiple abnorm Mental disorders of mother Neck muscle torsion of No drug reaction Non-toxic multinodular goitre Non-toxic nodular goitre Non-toxic uninodular goitre Pseudothrombocytopaenia Spinal fluid abnorm Synovitis wrists & feet Thrombocytopaenia Visual evoked potentials abnorm. Back Featured SMQ Changes New SMQs

19 1. 1. Adverse pregnancy outcome/reproductive toxicity (incl neonatal disorders) (SMQ) Adverse pregnancy outcome/reproductive Toxicity (incl neonatal disorders (SMQ) Reproductive toxicity (SMQ) PTs=115 LLTs=529 Pregnancy complications PTs=200 LLTs=1443 Congenital, familial and genetic disorders PTs=1010 LLTs=2847 Disorders of the offspring PTs=245 LLTs= Convulsions (SMQ) Convulsions (SMQ) PTs=52 LLTs= Cardiac failure (SMQ) - has broad and narrow terms search option. CIOMS working group is requesting input from users regarding the development of an algorithm for this SMQ. Cardiac Failure (SMQ) PTs=51 LLTs= Dementia (SMQ)

20 Dementia (SMQ) PTs=76 LLTs= Embolic and thrombotic events (SMQ) Embolic and thrombotic events (SMQ) Embolic and thrombotic events, arterial (SMQ) PTs=95 LLTs=403 Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) PTs=98 LLTs=334 Embolic and thrombotic events, venous (SMQ) PTs=65 LLTs= Extrapyramidal syndrome (SMQ) Extrapyramidal syndrome (SMQ) Akathisia (SMQ) PTs=8 LLTs=62 Dyskinesia PTs=18 LLTs=113 Dystonia PTs=31 LLTs=203 Parkinson-like events PTs=30 LLTs= Malignancies (SMQ)

21 Malignancies (SMQ) Malignant or unspecified tumours (SMQ) PTs=1385 LLTs=6888 Malignancy related conditions (SMQ) PTs=35 LLTs=72 Malignancy related therapeutic and diagnostic procedures (SMQ) PTs=321 LLTs=805 Tumour makers (SMQ) PTs=19 LLTs=55 8. Pre-malignant disorders (SMQ) Premalignant disorders (SMQ) Blood premalignant disorders (SMQ) PTs=32 LLTs=118 Gastrointestinal premalignant disorders (SMQ) PTs=81 LLTs=262 Reproductive premalignant disorders (SMQ) PTs=37 LLTs=125 Skin premalignant disorders (SMQ) PTs=18 LLTs=91 9. Pseudomembranous colitis (SMQ) Pseudomembranous colitis (SMQ) PTs=29 LLTs=153

22 Back to New SMQs Back to MedDRA Changes Highlights Back to MedDRA 10.0 Review

23 MedDRA Version 10.0 Terminology Frequency Distribution by MedDRA Version Level Version Version Version Version Version Version Version SOC HLGT HLT 1,681 1,681 1,683 1,683 1,682 1,682 1,682 PT 16,449 16,559 16,751 16,976 17,320 17,505 17,719 LLT Current LLT's Non-current LLT's 61,204 52,253 8,951 61,704 52,740 8,964 62,348 53,370 8,978 62,950 53,967 8,983 63,817 54,834 8,983 64,620 55,621 8,999 65,147 56,125 9,022 Total 79,692 80,302 81,140 81,967 83,177 84,165 84,906 Back to MedDRA 10.0 Review

24 MedDRAVersion What's Coming Ahead? MedDRA terminology next release, version 10.1, is September SMQs in development/testing that will most likely be released in version 10.1 Acute central respiratory depression Gastrointestinal perforation, ulceration, haemorrhage or obstruction Oropharyngeal lesions Psychosis and psychotic disorders Thrombophlebitis Back to MedDRA Changes Highlights or Back to MedDRA 10.0 Review

MedDRA 10.1 Review. MedDRA Version 10.1 What s coming ahead? MedDRA Version Changes. General Remarks. Terminology Files: What you need to know

MedDRA 10.1 Review. MedDRA Version 10.1 What s coming ahead? MedDRA Version Changes. General Remarks. Terminology Files: What you need to know MedDRA 10.1 Review MedDRA Version Changes General Remarks Terminology Files: What you need to know MedDRA Version 10.1 Specific Changes Version 10.1 Changes Overview Changes in a Nutshell Changes Highlights

More information

What s New MedDRA Version 13.1

What s New MedDRA Version 13.1 What s New MedDRA Version 13.1 Acknowledgements ACKNOWLEDGEMENTS MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Adobe is a registered

More information

What s New MedDRA Version March

What s New MedDRA Version March C What s New MedDRA Version 21.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is registered by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and

More information

What s New MedDRA Version March

What s New MedDRA Version March c What s New MedDRA Version 20.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be

More information

What s New MedDRA Version 14.0

What s New MedDRA Version 14.0 What s New MedDRA Version 14.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Adobe is a registered

More information

MedDRA 13.0 Review. General Remarks. Version 13.0 Changes Overview. Changes in a Nutshell. Changes Highlights. MedDRA Version Changes

MedDRA 13.0 Review. General Remarks. Version 13.0 Changes Overview. Changes in a Nutshell. Changes Highlights. MedDRA Version Changes MedDRA 13.0 Review MedDRA Version Changes General Remarks MedDRA Version 13.0 Specific Changes Version 13.0 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 13.0 Terminology Frequency

More information

What s New MedDRA Version MSSO-DI March 2016

What s New MedDRA Version MSSO-DI March 2016 c What s New MedDRA Version 19.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be

More information

MedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell

MedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell MedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell Changes Highlights MedDRA Version 14.0 Terminology Frequency

More information

What s New MedDRA Version 15.1

What s New MedDRA Version 15.1 What s New MedDRA Version 15.1 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be

More information

What s New MedDRA Version 18.0

What s New MedDRA Version 18.0 What s New MedDRA Version 18.0 Acknowledgements ACKNOWLEDGEMENTS MedDRA trademark is owned by IFPMA on behalf of ICH. Disclaimer and Copyright Notice This document is protected by copyright and may be

More information

MedDRA Overview A Standardized Terminology

MedDRA Overview A Standardized Terminology MedDRA Overview A Standardized Terminology Patrick Revelle Director, MedDRA MSSO 6 May 2010 MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations

More information

Overview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs)

Overview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs) Overview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs) Judy Harrison Chief Medical Officer MedDRA MSSO 22 October 2013 MedDRA Data

More information

MedDRA Basic Concept

MedDRA Basic Concept MedDRA Basic Concept Pansie Zhang MSD R&D (China) Co., Ltd 23Apr2015 Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not

More information

Premium Specialty: Pediatrics

Premium Specialty: Pediatrics Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium

More information

Case Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014

Case Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014 - 16Oct2014 Report Run Date: 20-Oct-2014 Data Lock Date: 16-Oct-2014 19:00:06 Earliest Reaction Date: 28-Oct-2009 MedDRA Version: MedDRA 17.0 Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine : Alle cases

More information

Proposed MedDRA Version 17.0 Complex Changes (July 2013)

Proposed MedDRA Version 17.0 Complex Changes (July 2013) Proposed MedDRA Version 17.0 Complex Changes (July 2013) MedDRA User Submitted Requests: 1. Add a new HLT Exserohilum infections to HLGT Fungal infectious disorders Submitter rationale: Adding this HLT

More information

Episodes of Care Risk Adjustment

Episodes of Care Risk Adjustment Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous

More information

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users on Data Output Release 3.14 Based on MedDRA Version 20.1 1 September 2017 Disclaimer and Copyright Notice

More information

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER ICH-Endorsed Guide for MedDRA Users on Data Output Release 3.6 Based on MedDRA Version 16.1 1 October 2013 Disclaimer and Copyright Notice This

More information

TN Bundled Payment Initiative: Overview of Episode Risk Adjustment

TN Bundled Payment Initiative: Overview of Episode Risk Adjustment TN Bundled Payment Initiative: Overview of Episode Risk Adjustment United Healthcare, April 2014 The State of Tennessee has implemented an episode-based approach to reimburse providers for the care delivered

More information

Implemented MedDRA Version 22.0 Complex Changes (October 2018)

Implemented MedDRA Version 22.0 Complex Changes (October 2018) Implemented MedDRA Version 22.0 Complex Changes (October 2018) MedDRA User Proposed Requests: 1. Move HLT Cardiac disorders NEC from HLGT Cardiac disorder signs and symptoms to new HLGT Cardiac disorders

More information

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty 666700 Acne Family Medicine, Internal Medicine, Pediatrics 438300 Acute Bronchitis Allergy,

More information

TN Bundled Payment Initiative: Overview of Episode Risk Adjustment

TN Bundled Payment Initiative: Overview of Episode Risk Adjustment TN Bundled Payment Initiative: Overview of Episode Risk Adjustment Amerigroup, April 2014 The State of Tennessee has implemented an episode-based approach to reimburse providers for the care delivered

More information

APR-DRG Description Ave Charge

APR-DRG Description Ave Charge Abdominal Pain 16,500.25 2.8 6,000.09 Acute & Subacute Endocarditis 15,339.30 3.0 5,113.10 Acute Myocardial Infarction 17,687.46 2.6 6,802.87 Alcohol Abuse & Dependence 19,126.64 4.2 4,553.96 Alcoholic

More information

Annual High Claims Survey. Year Ending 31 December 2016

Annual High Claims Survey. Year Ending 31 December 2016 Annual High Claims Survey Year Ending 31 December 2016 Released July 2017 Summary The Private Healthcare Australia Annual High Claims Survey Report analyses the nature and magnitude of high claims met

More information

VI.2. ELEMENTS FOR A PUBLIC SUMMARY

VI.2. ELEMENTS FOR A PUBLIC SUMMARY VI.2. ELEMENTS FOR A PUBLIC SUMMARY VI.2.1 Overview of Disease Epidemiology COCs containing DRSP-EE are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method

More information

GLUCOSE TESTING-BLOOD

GLUCOSE TESTING-BLOOD 648.83 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, ANTEPARTUM CONDITION OR 648.84 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, POSTPARTUM

More information

MedDRA - International standard for coding safety information. The Golden Triangle

MedDRA - International standard for coding safety information. The Golden Triangle MedDRA - International standard for coding safety information International Pharmacovigilance Conference Moscow, Russia 10 October 2018 Anna Zhao-Wong, MD, PhD MedDRA MSSO The Golden Triangle (MedDRA)

More information

Farmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI EKİM Dr.

Farmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI EKİM Dr. Farmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI 23-24 EKİM 2003 Dr. Tomás Moraleda Agenda 1. What is MedDRA? 2. Conditions before MedDRA 3. MedDRA

More information

Table of Contents. Course CME Credits. General Principles Topic CME Credit(s)

Table of Contents. Course CME Credits. General Principles Topic CME Credit(s) Table of Contents Course Course CME Credits Med-Challenger SPEX Comprehensive Review 266.0 CME Credits General Principles 21.0 CME Credit(s) Abdominal Pain 1.0 Acute Pelvic Pain in Women 1.0 Acute Vaginal

More information

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of

More information

Supplementary materials for:

Supplementary materials for: Supplementary materials for: Cecil E, Bottle A, Sharland M, Saxena S. Impact of UK primary care policy reforms on short-stay unplanned hospital admissions for children with primary care-sensitive conditions.

More information

DRG Code DRG Description FY18 Average Charge

DRG Code DRG Description FY18 Average Charge DRG Code DRG Description FY18 Average Charge 3 ECMO OR TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W MAJ O $ 665,511 4 TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. $ 422,497 37 EXTRACRANIAL

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney

More information

Data Analysis and Query Building with MedDRA

Data Analysis and Query Building with MedDRA Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The

More information

Hyperandrogenism and polycystic ovary syndrome are clear casual factors (trends) which result in hirsuitism and acne.

Hyperandrogenism and polycystic ovary syndrome are clear casual factors (trends) which result in hirsuitism and acne. VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Indication: Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism,

More information

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Nausicalm Cyclizine lactate 50 mg/ml solution for injection Presentation Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Uses Actions Cyclizine is a piperazine

More information

Perspective: E2B transmission

Perspective: E2B transmission Perspective: E2B transmission I2B(M) Information about the safety report itself A.1 Report identification A.2 Primary source of information A.3.1 Who sends the information A.3.2 Who receives it Case information

More information

Best practices in VeDDRA coding

Best practices in VeDDRA coding Best practices in VeDDRA coding 27 November 2013 Presented by: Giles Davis Chair of PhVWP-V VeDDRA sub-group An agency of the European Union Veterinary Dictionary for Drug Related Affairs SOC = System

More information

Emergency Medicine Scope of Practice

Emergency Medicine Scope of Practice Emergency Medicine Scope of Practice All Physician Assistants working in Emergency Medicine will encounter a wide variety of non acute, urgent and emergent patient complaints and conditions. Given the

More information

Patient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the

Patient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the Patient guide: Catheter occlusion of Patent Ductus Arteriosus with the pfm Nit-Occlud PDA coil occlusion system pfm Produkte für die Medizin - AG Wankelstr. 60 D - 50996 Cologne Phone: +49 (0) 2236 96

More information

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1 Appointment Date: Page 1 Chief Complaint: (Please write reason, symptoms, condition or diagnosis that prompts your appointment) Past Medical History PERSONAL SKIN HISTORY YES NO Yes - Details Melanoma

More information

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this

More information

2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis

2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis 2) Hospital case-fatality 2.1 Numerator: The number of denominator continuous inpatient spells (i.e. spells excluding those with a diagnosis of cancer anywhere in the spell) where the patient dies in hospital

More information

Safety Data Analysis and Query Creation with MedDRA

Safety Data Analysis and Query Creation with MedDRA Safety Data Analysis and Query Creation with MedDRA Anne Kehely & Eva Rump Eli Lilly/MSSO 24th Annual EuroMeeting 26-28 March 2012 Copenhagen, Denmark Insert your logo in this area then delete this text

More information

ANY FAMILY HISTORY OF ANEURYSM OR DVT?

ANY FAMILY HISTORY OF ANEURYSM OR DVT? NAME: D/O/B: DATE: MR# WHAT PROBLEM(S) BRINGS YOU HERE TODAY? WHO SENT YOU TO US? DOCTOR/OTHER WHICH DOCTOR? WHAT SURGERY HAVE YOU HAD AND WHEN? (LIST) 1. 2. 3. 4. 5. 6. 7. HOW MUCH ALCOHOL DO YOU DRINK

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records Riccardo Miotto 1,2, Li Li 1,2, Brian A. Kidd 1,2, and Joel T. Dudley

More information

Use of MedDRA in Special Situations

Use of MedDRA in Special Situations Use of MedDRA in Special Situations Patrick Revelle MedDRA MSSO 13 March 2012 Overview Existing terms in MedDRA for off-label use, abuse, misuse, overdose, and medication errors Current coding recommendations

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Williams CM, Maher CG, Latimer J, et al. Efficacy

More information

Inner Balance Acupuncture

Inner Balance Acupuncture Patient Information Inner Balance Acupuncture 274 Southland Drive, Suite 101, Lexington, KY 40503 859-595-2164 www.acupunctureky.com Name: Today s date: Age: Male Female Marital status: Date of Birth:

More information

SHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function

SHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may

More information

Preview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations

Preview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations Preview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations Judy Harrison, M.D. Chief Medical Officer MedDRA MSSO Information Day on Medication Errors 20 October 2016 London,

More information

CMS Limitations Guide MRA Radiology Services

CMS Limitations Guide MRA Radiology Services CMS Limitations Guide MRA Radiology Services Starting July 1, 2008, CMS has placed numerous medical necessity limits on tests and procedures. This reference guide provides you with all of the latest changes.

More information

Introductory Guide MedDRA Version 15.0

Introductory Guide MedDRA Version 15.0 Introductory Guide MedDRA Version 15.0 Acknowledgements Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory

More information

GLUCOSE TESTING-BLOOD

GLUCOSE TESTING-BLOOD Abnormal glucose tolerance complicating pregnancy, childbirth or the 648.83 puerperium, antepartum condition or complication Abnormal glucose tolerance complicating pregnancy, childbirth or the 648.84

More information

InterQual Level of Care 2018 Index

InterQual Level of Care 2018 Index InterQual Level of Care 2018 Index Long-Term Acute Care (LTAC) Criteria The Index is an alphabetical listing of conditions and/or diagnoses designed to guide the user to the criteria subset where a specific

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lind M, Polonsky W, Hirsch IB, et al. Effect of continuous glucose monitoring vs conventional therapy on glycemic control among patients type 1 diabetes treated multiple daily

More information

Medical Review Guidelines Magnetic Resonance Angiography

Medical Review Guidelines Magnetic Resonance Angiography Medical Review Guidelines Magnetic Resonance Angiography Medical Guideline Number: MRG2001-05 Effective Date: 2/13/01 Revised Date: 2/14/2006 OHCA Reference OAC 317:30-5-24. Radiology. (f) Magnetic Resonance

More information

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS:

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: 1 NAME: DATE OF BIRTH PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: PAST MEDICAL HISTORY (YOUR MEDICAL HISTORY) :

More information

SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC 84, ,037.80

SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC 84, ,037.80 Inpatient Visits by DRG Inpatient Discharges between 10/01/17 and 09/30/18 DRG DRG Description Average Charge Self-Pay Price VAGINAL DELIVERY W/O COMPLICATING 775 DIAGNOSES 14,680.67 5,578.66 795 NORMAL

More information

0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia

0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia Certain infectious and parasitic diseases 0101 Intestinal infectious diseases 0102 Tuberculosis 0103 Infections with a predominantly sexual mode of transmission 0104 Viral infections characterized by skin

More information

CUMULATIVE ILLNESS RATING SCALE (CIRS)

CUMULATIVE ILLNESS RATING SCALE (CIRS) CUMULATIVE ILLNESS RATING SCALE (CIRS) The CIRS used in this protocol is designed to provide an assessment of recurrent or ongoing chronic comorbid conditions, classified by 14 organ systems. Using the

More information

Data retrieval using the new SMQ Medication Errors

Data retrieval using the new SMQ Medication Errors Data retrieval using the new SMQ Medication Errors Christina Winter Medical Director Safety Evaluation and Risk Management, GSK Information Day on Medication Errors 20 October 2016 London, UK Disclaimer

More information

Appendix Criteria used for the automated chart review

Appendix Criteria used for the automated chart review Appendix Criteria used for the automated chart review A. Heart attack i. 410.01 (Acute myocardial infarction of anterolateral wall initial episode of ii. 410.11 (Acute myocardial infarction of other anterior

More information

INGENIX Ingenix

INGENIX Ingenix New, Revised, and Invalid ICD-9-CM Codes for Fiscal 2012 The following code lists contain the new, revised, and invalid ICD-9-CM codes effective October 1, 2011, as approved by the ICD-9-CM Coordination

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR: Core Safety Profile Active substance: Carteolol Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% P - RMS: SK/H/PSUR/0002/002 Date of FAR: 16.03.2012 4.1 THERAPEUTIC INDICATIONS Ocular hypertension

More information

BIRMINGHAM VASCULAR ASSOCIATES, P.C. PATIENT MEDICAL HISTORY FORM

BIRMINGHAM VASCULAR ASSOCIATES, P.C. PATIENT MEDICAL HISTORY FORM PATIENT MEDICAL HISTORY FORM Name: Date: Social Security #: DOB: Height: Weight: Email: Primary Care Physician: Referred by: Pharmacy Name/Location/Phone Number: Dialysis Center and Phone Number (if applicable):

More information

A Pause in the Availability of Risk Adjusted National Benchmarks for AHRQ Indicators and an Alternative Measurement Approach

A Pause in the Availability of Risk Adjusted National Benchmarks for AHRQ Indicators and an Alternative Measurement Approach A Pause in the Availability of Risk Adjusted National Benchmarks for AHRQ Indicators and an Alternative Measurement Approach Joseph Greenway, MPH Director of the Center for Health Information Analysis

More information

Present-on-Admission (POA) Coding

Present-on-Admission (POA) Coding 1 Present-on-Admission (POA) Coding Michael Pine, MD, MBA Michael Pine and Associates, Inc 2 POA and Coding Guidelines (1) Unless otherwise specified, a POA modifier must be assigned to each principal

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

City State Zip. Cell Phone. Other Phone. Gender Male Female Status Single Married Divorced Widowed. Height Weight EXERCISE Yes No Times per Week

City State Zip. Cell Phone. Other Phone. Gender Male Female Status Single Married Divorced Widowed. Height Weight EXERCISE Yes No Times per Week Patient Name (First Middle Last) Date of Birth Social Security # Address City State Zip Home Phone Work Phone Cell Phone Other Phone Email Place of Birth Occupation Retired Yes No Gender Male Female Status

More information

Pharmacotherapy Handbook

Pharmacotherapy Handbook Pharmacotherapy Handbook Eighth Edition Barbara G. Wells, PharmD, HP, FCCP, BCPP Dean and Professor Executive Director, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University

More information

STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL

STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL MAIN OFFICE: (618) 692-7478 MORGUE: (618) 296-4525 FAX: (618) 692-6042 FAX: (618) 692-9304 STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL. 62025-1962

More information

Chiropractic Applied Kinesiology Vitamins Herbs Homeopathy Health Education Classes PATIENT REGISTRATION

Chiropractic Applied Kinesiology Vitamins Herbs Homeopathy Health Education Classes PATIENT REGISTRATION Chiropractic Applied Kinesiology Vitamins Herbs Homeopathy Health Education Classes PATIENT REGISTRATION Name Date Address City State Zip Home Phone Cell Phone # Work: Email Address Occupation Employer

More information

Attending Physician s Statement

Attending Physician s Statement ( Form A A This form is used for claiming the social insurance benefit. This form should be completed and signed by the attending physician outpatient and One form for each month, one form for hospitalization

More information

Selected tables standardised to Segi population

Selected tables standardised to Segi population Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission

More information

Life Care Plan. Eric Henderson Potential Complications For Information Purposes Only. No Prediction of Frequency of Occurrence Available.

Life Care Plan. Eric Henderson Potential Complications For Information Purposes Only. No Prediction of Frequency of Occurrence Available. Cost of Potential s Arthritis Greater risk for developing arthritis due to orthopedic injuries. Arthroplasty $26,800 - $29,000 Replacement of hip joint due to bone disease. Autonomic Dysreflexia (exaggerated

More information

Care of the Deteriorating Patient in Recovery NADIA TICEHURST : CLINICAL NURSE EDUCATOR PERI ANAESTHETICS BENDIGO HEALTH

Care of the Deteriorating Patient in Recovery NADIA TICEHURST : CLINICAL NURSE EDUCATOR PERI ANAESTHETICS BENDIGO HEALTH Care of the Deteriorating Patient in Recovery NADIA TICEHURST : CLINICAL NURSE EDUCATOR PERI ANAESTHETICS BENDIGO HEALTH Intended learning outcomes Describe the components of a comprehensive clinician

More information

ANAESTHESIA QUESTIONNAIRE: (TO BE COMPLETED BY THE PATIENT (POSSIBLY TOGETHER WITH THE GP))

ANAESTHESIA QUESTIONNAIRE: (TO BE COMPLETED BY THE PATIENT (POSSIBLY TOGETHER WITH THE GP)) Version No. 1.0 Valid from dec 2016 Document number DC 491 Unit Anaesthesia ANAESTHESIA QUESTIONNAIRE: (TO BE COMPLETED BY THE PATIENT (POSSIBLY TOGETHER WITH THE GP)) Together with your treating physician,

More information

DNA CENTER New Patient Information

DNA CENTER New Patient Information DNA CENTER New Patient Information Name Email: Address City State Zip Home Phone Work Cell Phone Social Security Number Date of birth Gender ( Male/Female) Age Please Circle: Hispanic/Latin or Non Hispanic/Latin

More information

Interventional Pain Medicine. P. Tennent Slack, M.D. Dr. Greg Jackson, M.D. Ben Fleming, PA-C

Interventional Pain Medicine. P. Tennent Slack, M.D. Dr. Greg Jackson, M.D. Ben Fleming, PA-C Interventional Pain Medicine P. Tennent Slack, M.D. Dr. Greg Jackson, M.D. Ben Fleming, PA-C Gainesville Braselton Medical Park 1, Suite 300 Medical Plaza B, Suite 402 1315 Jesse Jewell Parkway 1404 River

More information

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes Acute Seizure, Syncope, Acute Gastroenteritis, Pediatric Pneumonia, Bronchiolitis, Colposcopy, Hysterectomy,

More information

Patient Name (First, Middle, Last) Height Weight. Ethnicity Race Language. Address. City State Zip. Home Phone Cell Phone. Work Phone Other Phone

Patient Name (First, Middle, Last) Height Weight. Ethnicity Race Language. Address. City State Zip. Home Phone Cell Phone. Work Phone Other Phone Patient Name (First, Middle, Last) Height Weight Date of Birth Social Security # Gender Male Female Ethnicity Race Language Address City State Zip Home Phone Cell Phone Work Phone Other Phone Email Occupation

More information

Data Analysis and Query Building with MedDRA

Data Analysis and Query Building with MedDRA Data Analysis and Query Building with MedDRA MedDRA was developed under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The

More information

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all Family Health History Please answer each question as honestly as possible. There are no right or wrong answers to nay of the questions. It is important that you answer as many questions as you can. We

More information

This week we saw a total of 85 patients, 25 of whom were unable to pay because of limited financial resources.

This week we saw a total of 85 patients, 25 of whom were unable to pay because of limited financial resources. February 2014 Honduras New Hope Clinic Weekly Reports Weekly Report Feb. 3-7, 2014 This week we saw a total of 85 patients, 25 of whom were unable to pay because of limited This week the clinic donated

More information

Patient Name Date of Birth Age. Other phone ( ) . Other

Patient Name Date of Birth Age. Other phone ( )  . Other GASTROINTESTINAL & MINIMALLY INVASIVE SURGERY HEALTH HISTORY QUESTIONNAIRE Date Patient Name _ Date of Birth Age Daytime phone ( ) Other phone ( ) Email How did you hear about us? My doctor Yellow pages

More information

Emergency Care Progress Log

Emergency Care Progress Log Emergency Care Progress Log For further details on the National Occupational Competencies for EMRs, please visit www.paramedic.ca. Check off each skill once successfully demonstrated the Instructor. All

More information

Intensity: 0-10 (10 is the worse pain you have ever experienced in your life that you would want to jump from a building, 0 is no pain)

Intensity: 0-10 (10 is the worse pain you have ever experienced in your life that you would want to jump from a building, 0 is no pain) Patient Questionnaire: Name: Date: Occupation: Date of Birth: Age: Sex: Male Female Referring Physician: Chief Complaint: Describe your Pain: sudden onset gradual constant intermittent worsening improving

More information

Synopsis Style Clinical Study Report SR EFC10139 Version number: 1 (electronic 2.0)

Synopsis Style Clinical Study Report SR EFC10139 Version number: 1 (electronic 2.0) SYNOPSIS Title of the study: A randomized, double-blind, parallel-group, multicenter, multinational study to assess the long-term effect, over 1 year, of rimonabant 10 mg in comparison with rimonabant

More information

Primary (First) Complaint and Location

Primary (First) Complaint and Location Name: : File #: Case Type: Sex: Birth : Age: Social Security #: Address: Residence and Mailing City State Zip Code Home Phone: Mobile Phone: Email: Occupation: Employer: Work Phone: Marital Status: S M

More information

The determination of eligible population for this measure requires administrative claims data.

The determination of eligible population for this measure requires administrative claims data. Overuse of Imaging Measure 6: Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Headache Description This measure assesses the ratio

More information

Nursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN

Nursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN Nursing Care of the Dialysis Patient Adrian Hordon, MSN, RN Understand principles of hemodialysis Recognize different access ports Identify side effects and complications Discuss nursing care for pre and

More information

Introductory Guide MedDRA Version 14.0

Introductory Guide MedDRA Version 14.0 Introductory Guide MedDRA Version 14.0 Notice to Reader Notice to Reader This Introductory Guide is written in English and is intended only for use with the English version of MedDRA. Additional Introductory

More information

NurseAchieve. CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NURSING SKILLS AND FUNDAMENTALS:

NurseAchieve.   CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NURSING SKILLS AND FUNDAMENTALS: NurseAchieve www.nurseachieve.com CHAPTERS INCLUDED IN THE NURSEACHIEVE COMPREHENSIVE NCLEX REVIEW NCLEX TEST STRATEGIES: NCLEX EXAM OVERVIEW TEST TAKING STRATEGIES NURSING SKILLS AND FUNDAMENTALS: ADMINISTRATION

More information

Case Series Drug Analysis Print Name: Isotretinoin

Case Series Drug Analysis Print Name: Isotretinoin Report Run Date: 30-Dec-2013 Data Lock Date: 27-Dec-2013 23:09:23 Earliest Reaction Date: 12-Jun-1997 MedDRA Version: MedDRA 16.1 Isotretinoin: No description provided. Report Run Date: 30-Dec-2013, Page

More information